Johns Hopkins Medicine Researchers Create Machine Learning Model to Calculate Chemotherapy Success in Patients With Osteosarcoma
November 03, 2023
November 03, 2023
BALTIMORE, Maryland, Nov. 3 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN) -- or, what percentage of a tumor is "dead" and no longer active -- in patients with osteosarcoma, a type of bone cancer. The model's calculation was 85% correct when compared to the results of a musculoskeletal pathologist. Upon removing one outlier, t . . .
A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN) -- or, what percentage of a tumor is "dead" and no longer active -- in patients with osteosarcoma, a type of bone cancer. The model's calculation was 85% correct when compared to the results of a musculoskeletal pathologist. Upon removing one outlier, t . . .